ANA773 Resumes Race Against Hepatitis C
admin By reaction the dosing schedule in half, Anadys Pharmaceuticals returns to their enquiry of ANA773, a Toll-Like Receptor-7 character prodrug. Approaching the Hepatitis C virus differently from most another contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load…
Posted in Hepatology |